MIR
Neutral signalScored 2026-10-20 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
Research, not advice.
À propos
Mirion Technologies, Inc.
- Nom
- Mirion Technologies, Inc.
- Secteur
- Industrials
- Industrie
- Industrial - Machinery
- Bourse
- NYSE
- Capitalisation
- $3.6B
- Employés
- 3,281
- PDG
- Thomas D. Logan
- Site web
- https://www.mirion.com
- Marché
- GTESGXOJBTMMIDDMOG-ANPO
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
ACHAT TOTAL: 20000 titres (~312000 USD)
- Insiders
- Schopfer Brian
- Total bought
-
$312,000
Avg buy (VWAP, 90d window) $15.60 vs last close $14.81 (-5.1%)
- Total sold
-
—
Avg sell (VWAP, 90d window) —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-09-02
- Liquidity
- Liquid $61,092,213/day · 20d vol
- Last synced
-
2026-10-23 21:10:44
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-02 | Schopfer Brian | Buy · P | 20,000 | $15.60 | $312,000 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-10-20 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
MIR presents a compelling turnaround story in 2025 with positive net profitability and improving margins, supported by strong liquidity (85) and solid fundamentals trend (75).
The first sentence of the analysis written for MIR on 2026-10-20 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Narrative Supports a bullish reading. Stored narrative reading is in the bullish band
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
- Financial indicators Supports a bullish reading. Current ratio 2.83 · operating margin 5.6%
Suggested stop 13.84, nearest stored support minus 0.5 ATR(6.5% under the last close). Reward/risk to the next stored resistance is 0.57. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Recent news
- 2026-10-15 Mirion Announces Earnings Release and Conference Call Date for Third Quarter 2026 ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for third quarter 2026 after market close on Tuesday, October 27, 2026. Following the news release, the company will host a conference call the next day, Wednesday, October 28, 2026, at 10:00 am ET to discuss the results. A live webcast and the subsequent replay will be available at https://mirion-3q-2026.open-exchange.net. About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, s.
- 2026-10-14 A Look at Mirion Technologies Inc (MIR) After 3.2% Decline -- GF Value $15.60 vs Price $15.90 On October 14, 2026, Mirion Technologies Inc (MIR) shares fell 3.2%, closing at $15.90. The stock has experienced significant volatility over the past year, wit
- 2026-10-09 Does Mirion Technologies (MIR) Have the Potential to Rally 47.97% as Wall Street Analysts Expect? The average of price targets set by Wall Street analysts indicates a potential upside of 48% in Mirion Technologies (MIR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 2026-09-29 Mirion Technologies (MIR) Upgraded to Buy: Here''s What You Should Know Mirion Technologies (MIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 2026-09-28 Mirion Technologies to Host Inaugural Mirion Connect EMEA/APAC Conference in Brussels BRUSSELS--(BUSINESS WIRE)--Mirion Technologies, a leading provider of advanced radiation safety solutions, today announced Mirion Connect 2026 EMEA/APAC, the company''s first regional edition of its Mirion Connect conference for Europe, the Middle East, Africa and Asia-Pacific region. The event will take place September 29 – October 1, 2026, in Brussels, Belgium. Mirion Connect, an event hosted in the United States for 40 years, brings together nuclear and radiation safety professionals from aro.
- 2026-09-25 Implied Volatility Surging for Mirion Technologies Stock Options Investors need to pay close attention to MIR stock based on the movements in the options market lately.
- 2026-09-23 Mirion Technologies: Unique Appeal Mirion Technologies has a unique position in the nuclear energy sector as an enabler for nuclear technology companies. The company has revenue growth and profits, with not a small adjusted EBITDA margin to prove its merit as well. As the nuclear energy sector matures further, so can MIR. While its rising debt can be concerning at a time of rising interest rates, MIR looks capable of riding it out. In the meantime, its market multiples are attractive.
- 2026-09-08 Mirion CFO Brian Schopfer Buys 20,000 The stock price has declined over the past 12 months, so this insider purchase reflects confidence in the company.
- 2026-09-03 Mirion Technologies Inc (MIR) Stock Up 7.6% but GF Value Says Overvalued -- GF Score: 53/100 On September 03, 2026, Mirion Technologies Inc (MIR) shares rose 7.6% to a current price of $16.76. This price is within a 52-week range of $14.11 to $30.28, in
- 2026-08-24 Why the Nuclear Sector Still Has Room to Grow Since the announcement of Microsoft (MSFT) working with Constellation Energy (CEG) to restart a reactor at the Three Mile Island plant, publicly traded companies in the nuclear sector have seen significant stock price changes.
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 47.4% | 46.7% | 44.5% | 44.2% | 42.5% | |
| Ebit Margin | 8.1% | 3.3% | -1.7% | -9.8% | -2.9% | |
| Ebitda Margin | 23.0% | 20.8% | 18.6% | 14.5% | 6.5% | |
| Operating Profit Margin | 5.6% | 2.9% | -2.7% | -41.5% | -10.3% | |
| Pretax Profit Margin | 3.5% | -3.9% | -13.1% | -42.7% | -34.2% | |
| Continuous Operations Profit Margin | 3.2% | -4.3% | -12.3% | -40.2% | -33.4% | |
| Net Profit Margin | 3.1% | -4.2% | -12.1% | -38.6% | -33.3% | |
| Bottom Line Profit Margin | 3.1% | -4.2% | -12.1% | -38.6% | -33.3% | |
| Current Ratio | 2.827 | 2.257 | 2.027 | 1.967 | 2.052 | |
| Quick Ratio | 2.345 | 1.751 | 1.485 | 1.381 | 1.492 | |
| Solvency Ratio | 0.100 | 0.106 | 0.056 | -0.081 | -0.120 | |
| Cash Ratio | 1.304 | 0.665 | 0.485 | 0.301 | 0.380 | |
| Price To Earnings Ratio | 180.154 | -96.944 | -20.918 | -4.320 | -17.164 | |
| Price To Earnings Growth Ratio | -1.046 | 1.532 | 0.308 | -0.029 | -0.634 | |
| Forward Price To Earnings Growth Ratio | -1.046 | 1.532 | 0.308 | -0.029 | -0.634 | |
| Price To Earnings Diluted Ratio | 212.909 | -96.944 | -20.918 | -4.320 | -17.164 | |
| Price To Earnings Diluted Growth Ratio | -1.322 | 1.532 | 0.308 | -0.029 | -0.634 | |
| Price To Book Ratio | 2.886 | 2.376 | 1.356 | 0.856 | 1.287 | |
| Price To Sales Ratio | 5.820 | 4.156 | 2.513 | 1.668 | 3.260 | |
| Price To Free Cash Flow Ratio | 50.380 | 71.115 | 34.643 | 230.268 | -130.457 | |
| Price To Operating Cash Flow Ratio | 37.583 | 36.096 | 21.143 | 30.391 | 2,420.709 | |
| Debt To Assets Ratio | 0.344 | 0.273 | 0.265 | 0.310 | 0.276 | |
| Debt To Equity Ratio | 0.661 | 0.478 | 0.486 | 0.608 | 0.508 | |
| Debt To Capital Ratio | 0.398 | 0.323 | 0.327 | 0.378 | 0.337 | |
| Long Term Debt To Capital Ratio | 0.391 | 0.313 | 0.316 | 0.364 | 0.323 | |
| Financial Leverage Ratio | 1.922 | 1.751 | 1.831 | 1.959 | 1.841 | |
| Working Capital Turnover Ratio | 2.037 | 2.850 | 3.146 | 3.063 | 3.047 | |
| Operating Cash Flow Ratio | 0.453 | 0.376 | 0.358 | 0.161 | 0.004 | |
| Operating Cash Flow Sales Ratio | 0.155 | 0.115 | 0.119 | 0.055 | 0.001 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.746 | 0.508 | 0.610 | 0.132 | -18.556 | |
| Debt Service Coverage Ratio | 4.795 | 2.983 | 2.466 | 2.563 | 0.769 | |
| Interest Coverage Ratio | 1.220 | 0.428 | -0.354 | -7.007 | -1.164 | |
| Short Term Operating Cash Flow Coverage Ratio | 89.562 | 82.583 | 79.333 | 7.434 | 0.231 | |
| Operating Cash Flow Coverage Ratio | 0.116 | 0.138 | 0.132 | 0.046 | 0.001 | |
| Capital Expenditure Coverage Ratio | 3.937 | 2.031 | 2.566 | 1.152 | 0.051 | |
| Dividend Paid And Capex Coverage Ratio | 3.937 | 2.031 | 2.566 | 1.152 | 0.051 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 29.155 | 23.027 | 17.483 | 18.921 | 68.250 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 47.4% | ▲0.7% | ▲2.3% |
| Ebit Margin | 8.1% | ▲4.8% | ▲8.7% |
| Ebitda Margin | 23.0% | ▲2.2% | ▲6.3% |
| Operating Profit Margin | 5.6% | ▲2.7% | ▲14.8% |
| Pretax Profit Margin | 3.5% | ▲7.5% | ▲21.6% |
| Continuous Operations Profit Margin | 3.2% | ▲7.5% | ▲20.6% |
| Net Profit Margin | 3.1% | ▲7.3% | ▲20.1% |
| Bottom Line Profit Margin | 3.1% | ▲7.3% | ▲20.1% |
| Current Ratio | 2.827 | ▲0.570 | ▲0.601 |
| Quick Ratio | 2.345 | ▲0.593 | ▲0.654 |
| Solvency Ratio | 0.100 | ▼-0.006 | ▲0.087 |
| Cash Ratio | 1.304 | ▲0.639 | ▲0.677 |
| Price To Earnings Ratio | 180.154 | ▲277.098 | ▲171.993 |
| Price To Earnings Growth Ratio | -1.046 | ▼-2.578 | ▼-1.072 |
| Forward Price To Earnings Growth Ratio | -1.046 | ▼-2.578 | ▼-1.072 |
| Price To Earnings Diluted Ratio | 212.909 | ▲309.853 | ▲198.197 |
| Price To Earnings Diluted Growth Ratio | -1.321 | ▼-2.854 | ▼-1.293 |
| Price To Book Ratio | 2.886 | ▲0.510 | ▲1.133 |
| Price To Sales Ratio | 5.820 | ▲1.664 | ▲2.337 |
| Price To Free Cash Flow Ratio | 50.380 | ▼-20.735 | ▼-0.810 |
| Price To Operating Cash Flow Ratio | 37.583 | ▲1.487 | ▼-471.601 |
| Debt To Assets Ratio | 0.344 | ▲0.071 | ▲0.050 |
| Debt To Equity Ratio | 0.661 | ▲0.183 | ▲0.113 |
| Debt To Capital Ratio | 0.398 | ▲0.074 | ▲0.045 |
| Long Term Debt To Capital Ratio | 0.391 | ▲0.078 | ▲0.050 |
| Financial Leverage Ratio | 1.923 | ▲0.172 | ▲0.061 |
| Working Capital Turnover Ratio | 2.037 | ▼-0.813 | ▼-0.792 |
| Operating Cash Flow Ratio | 0.453 | ▲0.077 | ▲0.183 |
| Operating Cash Flow Sales Ratio | 0.155 | ▲0.040 | ▲0.066 |
| Free Cash Flow Operating Cash Flow Ratio | 0.746 | ▲0.238 | ▲4.058 |
| Debt Service Coverage Ratio | 4.795 | ▲1.811 | ▲2.079 |
| Interest Coverage Ratio | 1.220 | ▲0.792 | ▲2.596 |
| Short Term Operating Cash Flow Coverage Ratio | 89.562 | ▲6.979 | ▲37.734 |
| Operating Cash Flow Coverage Ratio | 0.116 | ▼-0.021 | ▲0.029 |
| Capital Expenditure Coverage Ratio | 3.937 | ▲1.906 | ▲1.990 |
| Dividend Paid And Capex Coverage Ratio | 3.937 | ▲1.906 | ▲1.990 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 29.155 | ▲6.128 | ▼-2.212 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $5.39B | $3.58B | $2.01B | $1.20B | $2.18B | |
| Enterprise value | $6.21B | $4.12B | $2.60B | $1.97B | $2.96B | |
| EV / Sales | 6.71x | 4.79x | 3.25x | 2.75x | 4.42x | |
| EV / Op. cash flow | 43.31x | 41.59x | 27.36x | 50.09x | 3283.60x | |
| EV / Free cash flow | 58.06x | 81.94x | 44.84x | 379.52x | -176.96x | |
| EV / EBITDA | 29.16x | 23.03x | 17.48x | 18.92x | 68.25x | |
| Net debt / EBITDA | 3.86x | 3.04x | 3.97x | 7.44x | 17.93x | |
| Current ratio | 2.83x | 2.26x | 2.03x | 1.97x | 2.05x | |
| Income quality | 4.98x | -2.71x | -0.98x | -0.14x | -0.01x | |
| Graham number | $5 | — | — | — | — | |
| Graham net-net | -$4 | -$3 | -$4 | -$5 | -$5 | |
| Tax burden | 88.1% | 106.5% | 92.0% | 90.3% | 97.4% | |
| Interest burden | 43.7% | -118.5% | 763.0% | 436.8% | 1165.8% | |
| Working capital | $577.6M | $331.2M | $272.9M | $236.3M | $232.4M | |
| Invested capital | $3.24B | $2.35B | $2.43B | $2.47B | $2.87B | |
| Return on assets | 0.8% | -1.4% | -3.6% | -10.1% | -7.1% | |
| Operating ROA | 1.7% | 0.9% | -0.8% | -10.2% | -3.2% | |
| Return on tangible assets | 2.6% | -4.5% | -13.2% | -41.3% | -34.3% | |
| Return on equity | 1.5% | -2.4% | -6.5% | -19.8% | -13.1% | |
| Return on invested capital | 1.4% | 1.0% | -0.8% | -11.3% | -2.3% | |
| Return on capital employed | 1.6% | 1.0% | -0.9% | -11.9% | -2.4% | |
| Earnings yield | 0.5% | -1.0% | -4.8% | -23.1% | -10.2% | |
| Free cash flow yield | 2.0% | 1.4% | 2.9% | 0.4% | -0.8% | |
| Capex / Op. cash flow | 25.4% | 49.2% | 39.0% | 86.8% | 1955.6% | |
| Capex / Depreciation | 26.4% | 32.4% | 22.8% | 19.6% | 28.0% | |
| Capex / Sales | 3.9% | 5.7% | 4.6% | 4.8% | 2.6% | |
| SG&A / Sales | 37.6% | 39.3% | 42.3% | 49.7% | 40.0% | |
| R&D / Sales | 4.2% | 4.1% | 4.0% | 4.2% | 5.4% | |
| Stock comp / Sales | 1.6% | 1.8% | 2.7% | 4.4% | 0.0% | |
| Intangibles / Total assets | 69.1% | 69.7% | 73.1% | 75.5% | 79.2% | |
| Days sales outstanding | 114d | 107d | 105d | 115d | 120d | |
| Days payables outstanding | 43d | 45d | 48d | 62d | 56d | |
| Operating cycle | 229d | 213d | 223d | 245d | 237d | |
| Cash conversion cycle | 186d | 168d | 175d | 184d | 181d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years